North America is anticipated to hold 37.0% of the Atherosclerosis market in the assessment period 20
The Atherosclerosis Market is expected to be worth US$ 58,236.4 Million by 2032, growing at a CAGR of 2.8% between 2022 and 2032, from a current value of US$ 44,183.8 Million in 2022. The rising prevalence of cardiovascular diseases is a significant factor driving market growth.Atherosclerosis is the narrowing of th...